97 related articles for article (PubMed ID: 21256748)
1. Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection.
Zou XQ; Peng SM; Hu CP; Tan LF; Deng HW; Li YJ
Bioorg Med Chem Lett; 2011 Feb; 21(4):1222-6. PubMed ID: 21256748
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin.
Zou XQ; Peng SM; Hu CP; Tan LF; Yuan Q; Deng HW; Li YJ
Bioorg Med Chem; 2010 May; 18(9):3020-5. PubMed ID: 20395149
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.
Wang QQ; Cheng N; Yi WB; Peng SM; Zou XQ
Bioorg Med Chem; 2014 Mar; 22(5):1515-21. PubMed ID: 24508143
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors.
Peng SM; Zou XQ; Ding HL; Ding YL; Lin YB
Bioorg Med Chem Lett; 2009 Feb; 19(4):1264-6. PubMed ID: 19167219
[TBL] [Abstract][Full Text] [Related]
6. Water soluble furoxan derivatives as NO prodrugs.
Sorba G; Medana C; Fruttero R; Cena C; Di Stilo A; Galli U; Gasco A
J Med Chem; 1997 Feb; 40(4):463-9. PubMed ID: 9046336
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of furoxan-based nitric oxide-releasing glucocorticoid derivatives with potent anti-inflammatory activity and improved safety.
Fang L; Zhang Y; Lehmann J; Wang Y; Ji H; Ding D
Bioorg Med Chem Lett; 2007 Feb; 17(4):1062-6. PubMed ID: 17129724
[TBL] [Abstract][Full Text] [Related]
8. Caffeoylated phenylpropanoid glycosides from Brandisia hancei inhibit advanced glycation end product formation and aldose reductase in vitro and vessel dilation in larval zebrafish in vivo.
Yu SY; Lee IS; Jung SH; Lee YM; Lee YR; Kim JH; Sun H; Kim JS
Planta Med; 2013 Dec; 79(18):1705-9. PubMed ID: 24288293
[TBL] [Abstract][Full Text] [Related]
9. Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity.
Yoo NH; Jang DS; Yoo JL; Lee YM; Kim YS; Cho JH; Kim JS
J Nat Prod; 2008 Apr; 71(4):713-5. PubMed ID: 18298080
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr.
Wirasathien L; Pengsuparp T; Suttisri R; Ueda H; Moriyasu M; Kawanishi K
Phytomedicine; 2007 Aug; 14(7-8):546-50. PubMed ID: 17084603
[TBL] [Abstract][Full Text] [Related]
13. Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advanced glycation end products and rat lens aldose reductase in vitro.
Jang DS; Lee YM; Jeong IH; Kim JS
Arch Pharm Res; 2010 Jun; 33(6):875-80. PubMed ID: 20607492
[TBL] [Abstract][Full Text] [Related]
14. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.
Wang QQ; Cheng N; Zheng XW; Peng SM; Zou XQ
Bioorg Med Chem; 2013 Jul; 21(14):4301-10. PubMed ID: 23683835
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
17. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
[TBL] [Abstract][Full Text] [Related]
18. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
[TBL] [Abstract][Full Text] [Related]
19. Constituents of the flowers of Erigeron annuus with inhibitory activity on the formation of advanced glycation end products (AGEs) and aldose reductase.
Jang DS; Yoo NH; Lee YM; Yoo JL; Kim YS; Kim JS
Arch Pharm Res; 2008 Jul; 31(7):900-4. PubMed ID: 18704333
[TBL] [Abstract][Full Text] [Related]
20. Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.
Tosco P; Bertinaria M; Di Stilo A; Cena C; Sorba G; Fruttero R; Gasco A
Bioorg Med Chem; 2005 Aug; 13(15):4750-9. PubMed ID: 15946850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
